Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesDividends payablesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

cbdMD (YCBD) Liabilities and Shareholders Equity: 2016-2025

Historic Liabilities and Shareholders Equity for cbdMD (YCBD) over the last 10 years, with Sep 2025 value amounting to $10.4 million.

  • cbdMD's Liabilities and Shareholders Equity fell 1.53% to $10.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $42.8 million, marking a year-over-year decrease of 20.85%. This contributed to the annual value of $10.4 million for FY2025, which is 1.53% down from last year.
  • As of FY2025, cbdMD's Liabilities and Shareholders Equity stood at $10.4 million, which was down 1.53% from $10.6 million recorded in FY2024.
  • In the past 5 years, cbdMD's Liabilities and Shareholders Equity registered a high of $124.9 million during FY2021, and its lowest value of $10.4 million during FY2025.
  • Moreover, its 3-year median value for Liabilities and Shareholders Equity was $10.6 million (2024), whereas its average is $12.4 million.
  • In the last 5 years, cbdMD's Liabilities and Shareholders Equity rose by 12.67% in 2021 and then tumbled by 67.34% in 2022.
  • cbdMD's Liabilities and Shareholders Equity (MRY) stood at $124.9 million in 2021, then crashed by 67.34% to $40.8 million in 2022, then crashed by 60.30% to $16.2 million in 2023, then crashed by 34.66% to $10.6 million in 2024, then fell by 1.53% to $10.4 million in 2025.
  • Its Liabilities and Shareholders Equity stands at $10.4 million for FY2025, versus $10.6 million for FY2024 and $16.2 million for FY2023.